Talkspace, Inc.
$5.18
▲
0.39%
2026-04-21 09:43:00
www.talkspace.com
NCM: TALK
Explore Talkspace, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$865.45 M
Current Price
$5.18
52W High / Low
$5.2 / $2.22
Stock P/E
111.06
Book Value
$0.7
Dividend Yield
—
ROCE
2.68%
ROE
6.65%
Face Value
—
EPS
$0.04
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
598
Beta
1.14
Debt / Equity
—
Current Ratio
6.38
Quick Ratio
6.38
Forward P/E
23.5
Price / Sales
3.77
Enterprise Value
$771.2 M
EV / EBITDA
127.96
EV / Revenue
3.37
Rating
None
Target Price
$6.15
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Claritev Corporation | $22.45 | — | $349.35 M | — | 0.97% | 632.6% | $74.07 / $12.04 | $-10.51 |
| 2. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 3. | Schrödinger, Inc. | $12.8 | — | $944.96 M | — | -31.08% | -26.29% | $27.63 / $10.95 | $4.94 |
| 4. | 10x Genomics, Inc. | $24.59 | — | $3.14 B | — | -12.49% | -5.78% | $26.45 / $7.25 | $6.24 |
| 5. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
| 6. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 7. | Weave Communications, Inc. | $5.47 | — | $430.21 M | — | -24.81% | -37.56% | $11.32 / $4.24 | $1.05 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 63 M | 59.38 M | 54.31 M | 52.18 M | 48.72 M | — |
| Operating Profit | 3.83 M | 2.2 M | -1.79 M | -1.08 M | 0.57 M | — |
| Net Profit | 4.76 M | 3.25 M | -0.54 M | 0.32 M | 1.21 M | — |
| EPS in Rs | 0.03 | 0.02 | -0 | 0 | 0.01 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 228.87 M | 187.59 M | 150.04 M | 119.57 M |
| Operating Profit | 3.15 M | -4.5 M | -23.21 M | -77.02 M |
| Net Profit | 7.79 M | 1.15 M | -19.18 M | -79.67 M |
| EPS in Rs | 0.05 | 0.01 | -0.11 | -0.48 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 134.86 M | 138.68 M | 142.22 M | 156.25 M |
| Total Liabilities | 17.85 M | 21.28 M | 23.57 M | 28.72 M |
| Equity | 117.02 M | 117.39 M | 118.65 M | 127.54 M |
| Current Assets | 111.06 M | 130.18 M | 139.8 M | 152.56 M |
| Current Liabilities | 17.4 M | 19.02 M | 21.65 M | 27.32 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 8.53 M | 11.29 M | -16.39 M | -61.08 M |
| Investing CF | -28.88 M | -46.31 M | -0.14 M | -0.32 M |
| Financing CF | -19 M | -12.19 M | 1.9 M | 1.68 M |
| Free CF | -2.11 M | 5.84 M | -16.39 M | -61.08 M |
| Capex | -10.64 M | -5.44 M | -0.15 M | -0.35 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 25.02% | 25.49% | — | — |
| Earnings Growth % | 105.98% | 75.92% | — | — |
| Profit Margin % | 0.61% | -12.78% | -66.63% | — |
| Operating Margin % | -2.4% | -15.47% | -64.42% | — |
| Gross Margin % | 45.99% | 49.87% | 50.46% | — |
| EBITDA Margin % | -1.94% | -14.61% | -63.28% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.